Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus

Authors: Christel Schwegmann-Weßels, Sandra Bauer, Christine Winter, Luis Enjuanes, Hubert Laude, Georg Herrler

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Transmissible gastroenteritis virus (TGEV) has a sialic acid binding activity that is believed to be important for enteropathogenicity, but that has so far appeared to be dispensable for infection of cultured cells. The aims of this study were to determine the effect of sialic acid binding for the infection of cultured cells under unfavorable conditions, and comparison of TGEV strains and mutants, as well as the avian coronavirus IBV concerning their dependence on the sialic acid binding activity.

Methods

The infectivity of different viruses was analyzed by a plaque assay after adsorption times of 5, 20, and 60 min. Prior to infection, cultured cells were either treated with neuraminidase to deplete sialic acids from the cell surface, or mock-treated. In a second approach, pre-treatment of the virus with porcine intestinal mucin was performed, followed by the plaque assay after a 5 min adsorption time. A student's t-test was used to verify the significance of the results.

Results

Desialylation of cells only had a minor effect on the infection by TGEV strain Purdue 46 when an adsorption period of 60 min was allowed for initiation of infection. However, when the adsorption time was reduced to 5 min the infectivity on desialylated cells decreased by more than 60%. A TGEV PUR46 mutant (HAD3) deficient in sialic acid binding showed a 77% lower titer than the parental virus after a 5 min adsorption time. After an adsorption time of 60 min the titer of HAD3 was 58% lower than that of TGEV PUR46. Another TGEV strain, TGEV Miller, and IBV Beaudette showed a reduction in infectivity after neuraminidase treatment of the cultured cells irrespective of the virion adsorption time.

Conclusions

Our results suggest that the sialic acid binding activity facilitates the infection by TGEV under unfavorable environmental conditions. The dependence on the sialic acid binding activity for an efficient infection differs in the analyzed TGEV strains.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Laude H, van Reeth K, Penseart M: Porcine respiratory coronavirus: molecular features and virus-host interactions. Vet Res 1993, 24: 125-150.PubMed Laude H, van Reeth K, Penseart M: Porcine respiratory coronavirus: molecular features and virus-host interactions. Vet Res 1993, 24: 125-150.PubMed
3.
go back to reference Delmas B, Gelfi JL, Haridon R, Vogel LK, Sjostrom H, Noren O, Laude H: Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992, 357: 417-420. 10.1038/357417a0CrossRefPubMed Delmas B, Gelfi JL, Haridon R, Vogel LK, Sjostrom H, Noren O, Laude H: Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992, 357: 417-420. 10.1038/357417a0CrossRefPubMed
4.
go back to reference Schultze B, Krempl C, Ballesteros ML, Shaw L, Schauer R, Enjuanes L, Herrler G: Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J Virol 1996, 70: 5634-5637.PubMedCentralPubMed Schultze B, Krempl C, Ballesteros ML, Shaw L, Schauer R, Enjuanes L, Herrler G: Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J Virol 1996, 70: 5634-5637.PubMedCentralPubMed
5.
go back to reference Schwegmann-Weßels C, Zimmer G, Laude H, Enjuanes L, Herrler G: Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins. J Virol 2002, 76: 6037-6043. 10.1128/JVI.76.12.6037-6043.2002PubMedCentralCrossRefPubMed Schwegmann-Weßels C, Zimmer G, Laude H, Enjuanes L, Herrler G: Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins. J Virol 2002, 76: 6037-6043. 10.1128/JVI.76.12.6037-6043.2002PubMedCentralCrossRefPubMed
6.
go back to reference Bernard S, Laude H: Site-specific alteration of transmissible gastroenteritis virus spike protein results in markedly reduced pathogenicity. J Gen Virol 1995, 76: 2235-2241. 10.1099/0022-1317-76-9-2235CrossRefPubMed Bernard S, Laude H: Site-specific alteration of transmissible gastroenteritis virus spike protein results in markedly reduced pathogenicity. J Gen Virol 1995, 76: 2235-2241. 10.1099/0022-1317-76-9-2235CrossRefPubMed
7.
go back to reference Krempl C, Schultze B, Laude H, Herrler G: Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol 1997, 7: 3285-3287. Krempl C, Schultze B, Laude H, Herrler G: Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol 1997, 7: 3285-3287.
8.
go back to reference Krempl C, Ballesteros ML, Zimmer G, Enjuanes L, Klenk HD, Herrler G: Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. J Gen Virol 2000, 81: 89-496.CrossRef Krempl C, Ballesteros ML, Zimmer G, Enjuanes L, Klenk HD, Herrler G: Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. J Gen Virol 2000, 81: 89-496.CrossRef
9.
go back to reference Schwegmann-Weßels C, Herrler G: Sialic acids as receptor determinants for coronaviruses. Glycoconjug J 2006, 23: 51-58. 10.1007/s10719-006-5437-9CrossRef Schwegmann-Weßels C, Herrler G: Sialic acids as receptor determinants for coronaviruses. Glycoconjug J 2006, 23: 51-58. 10.1007/s10719-006-5437-9CrossRef
10.
go back to reference Schwegmann-Wessels C, Zimmer G, Schröder B, Breves G, Herrler G: Binding of transmissible gastroenteritis coronavirus to brush border membrane sialoglycoproteins. J Virol 2003, 77: 11846-11848. 10.1128/JVI.77.21.11846-11848.2003PubMedCentralCrossRefPubMed Schwegmann-Wessels C, Zimmer G, Schröder B, Breves G, Herrler G: Binding of transmissible gastroenteritis coronavirus to brush border membrane sialoglycoproteins. J Virol 2003, 77: 11846-11848. 10.1128/JVI.77.21.11846-11848.2003PubMedCentralCrossRefPubMed
11.
go back to reference Cone RA: Mucus. In Mucosal Immunology. 3rd edition. Edited by: Mestecky J, Bienenstock J, Lamm ME, Strober W, McGhee JR, Mayer L. Amsterdam: Elsevier Academic Press; 2005:49-72.CrossRef Cone RA: Mucus. In Mucosal Immunology. 3rd edition. Edited by: Mestecky J, Bienenstock J, Lamm ME, Strober W, McGhee JR, Mayer L. Amsterdam: Elsevier Academic Press; 2005:49-72.CrossRef
12.
go back to reference Bohl EH, Gupta RK, Olquin MV, Saif LJ: Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus. Infect Immun 1972,6(3):289-301.PubMedCentralPubMed Bohl EH, Gupta RK, Olquin MV, Saif LJ: Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus. Infect Immun 1972,6(3):289-301.PubMedCentralPubMed
13.
go back to reference Sánchez CM, Gebauer F, Suné C, Mendez A, Dopazo J, Enjuanes L: Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology 1992, 190: 92-105. 10.1016/0042-6822(92)91195-ZCrossRefPubMed Sánchez CM, Gebauer F, Suné C, Mendez A, Dopazo J, Enjuanes L: Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology 1992, 190: 92-105. 10.1016/0042-6822(92)91195-ZCrossRefPubMed
14.
go back to reference Winter C, Schwegmann-Weßels C, Cavanagh D, Neumann U, Herrler G: Sialic acid is a receptor determinant for infection of cells by avian Infectious bronchitis virus. J Gen Virol 2006, 87: 1209-1216. 10.1099/vir.0.81651-0CrossRefPubMed Winter C, Schwegmann-Weßels C, Cavanagh D, Neumann U, Herrler G: Sialic acid is a receptor determinant for infection of cells by avian Infectious bronchitis virus. J Gen Virol 2006, 87: 1209-1216. 10.1099/vir.0.81651-0CrossRefPubMed
15.
go back to reference Winter C, Herrler G, Neumann U: Infection of the tracheal epithelium by infectious bronchitis virus is sialic acid dependent. Microbes Infect 2008, 10: 367-373. 10.1016/j.micinf.2007.12.009CrossRefPubMed Winter C, Herrler G, Neumann U: Infection of the tracheal epithelium by infectious bronchitis virus is sialic acid dependent. Microbes Infect 2008, 10: 367-373. 10.1016/j.micinf.2007.12.009CrossRefPubMed
16.
go back to reference Schwegmann C, Zimmer G, Yoshino T, Enss M, Herrler G: Comparison of the sialic acid binding activity of transmissible gastroenteritis coronavirus and E.coli K99. Virus Res 2001,75(1):69-73. 10.1016/S0168-1702(01)00228-3CrossRefPubMed Schwegmann C, Zimmer G, Yoshino T, Enss M, Herrler G: Comparison of the sialic acid binding activity of transmissible gastroenteritis coronavirus and E.coli K99. Virus Res 2001,75(1):69-73. 10.1016/S0168-1702(01)00228-3CrossRefPubMed
17.
go back to reference Schultze B, Herrler G: Bovine coronavirus uses N-acetyl-9-O-acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells. J Gen Virol 1992, 73: 901-906. 10.1099/0022-1317-73-4-901CrossRefPubMed Schultze B, Herrler G: Bovine coronavirus uses N-acetyl-9-O-acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells. J Gen Virol 1992, 73: 901-906. 10.1099/0022-1317-73-4-901CrossRefPubMed
18.
go back to reference Vlasak R, Luytjes W, Spaan W, Palese P: Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci USA 1988, 85: 4526-4529. 10.1073/pnas.85.12.4526PubMedCentralCrossRefPubMed Vlasak R, Luytjes W, Spaan W, Palese P: Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci USA 1988, 85: 4526-4529. 10.1073/pnas.85.12.4526PubMedCentralCrossRefPubMed
19.
go back to reference Sánchez CM, Jiménez G, Laviada MD, Correa I, Suñé C, Bullido MJ, Gebauer F, Smerdou C, Callebaut P, Escribano JM, Enjuanes L: Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology 1990, 174: 410-417. 10.1016/0042-6822(90)90094-8CrossRefPubMed Sánchez CM, Jiménez G, Laviada MD, Correa I, Suñé C, Bullido MJ, Gebauer F, Smerdou C, Callebaut P, Escribano JM, Enjuanes L: Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology 1990, 174: 410-417. 10.1016/0042-6822(90)90094-8CrossRefPubMed
20.
go back to reference Abd El Rahman S, El-Kenawy AA, Neumann U, Herrler G, Winter C: Comparative analysis of the sialic acid binding activity and the tropism for the respiratory epithelium of four different strains of avian infectious bronchitis virus. Avian Pathol 2009,38(1):41-45. 10.1080/03079450802632049CrossRefPubMed Abd El Rahman S, El-Kenawy AA, Neumann U, Herrler G, Winter C: Comparative analysis of the sialic acid binding activity and the tropism for the respiratory epithelium of four different strains of avian infectious bronchitis virus. Avian Pathol 2009,38(1):41-45. 10.1080/03079450802632049CrossRefPubMed
Metadata
Title
The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus
Authors
Christel Schwegmann-Weßels
Sandra Bauer
Christine Winter
Luis Enjuanes
Hubert Laude
Georg Herrler
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-435

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.